These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31841273)

  • 21. Disposable bioreactors: maturation into pharmaceutical glycoprotein manufacturing.
    Brecht R
    Adv Biochem Eng Biotechnol; 2009; 115():1-31. PubMed ID: 19517075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.
    Sabalza M; Christou P; Capell T
    Biotechnol Lett; 2014 Dec; 36(12):2367-79. PubMed ID: 25048244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A SIMPLIFIED METHOD FOR THE CLONING OF HETEROPLOID AND DIPLOID MAMMALIAN CELLS.
    FREEMAN AE; WARD TG; WOLFORD RG
    Proc Soc Exp Biol Med; 1964 Jun; 116():339-43. PubMed ID: 14189133
    [No Abstract]   [Full Text] [Related]  

  • 24. Analytical assessment of clonal derivation of eukaryotic/CHO cell populations.
    Aebischer-Gumy C; Moretti P; Little TA; Bertschinger M
    J Biotechnol; 2018 Nov; 286():17-26. PubMed ID: 30172783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation.
    McGrath S; Antonucci J; Goldstein N; Wallace M; Mitchell C; Grills I; Jolly S; Kestin L; Vicini F
    Am J Clin Oncol; 2010 Feb; 33(1):17-22. PubMed ID: 19636236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Throughput Optimization of Continuous Biopharmaceutical Manufacturing Facilities.
    Garcia FA; Vandiver MW
    PDA J Pharm Sci Technol; 2017; 71(3):189-205. PubMed ID: 27974629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA; Antonucci JV; Goldstein N; Wallace M; Kestin L; Krauss D; Kunzmann J; Gilbert S; Schell S
    Cancer; 2007 Apr; 109(7):1264-72. PubMed ID: 17372920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopharmaceutical Industry Practices for Sequence Variant Analyses of Recombinant Protein Therapeutics.
    Valliere-Douglass J; Marzilli L; Deora A; Du Z; He L; Kumar SR; Liu YH; Mueller HM; Nwosu C; Stults J; Wang Y; Yaghmour S; Zhou Y
    PDA J Pharm Sci Technol; 2019; 73(6):622-634. PubMed ID: 31209169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of cell line development in the GS-CHO expression system using a high-throughput, single cell-based clone selection system.
    Nakamura T; Omasa T
    J Biosci Bioeng; 2015 Sep; 120(3):323-9. PubMed ID: 25792187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning of hybridoma cell lines by limiting dilution.
    Fuller SA; Takahashi M; Hurrell JG
    Curr Protoc Mol Biol; 2001 May; Chapter 11():Unit11.8. PubMed ID: 18265080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning by limiting dilution: an improved estimate that an interesting culture is monoclonal.
    Staszewski R
    Yale J Biol Med; 1984; 57(6):865-8. PubMed ID: 6537695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of therapeutic antibody candidates derived from mini-pool and clonal cell lines.
    Fan L; Rizzi G; Bierilo K; Tian J; Yee JC; Russell R; Das TK
    Biotechnol Prog; 2017 Nov; 33(6):1456-1462. PubMed ID: 28393481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerating patient access to novel biologics using stable pool-derived product for non-clinical studies and single clone-derived product for clinical studies.
    Munro TP; Le K; Le H; Zhang L; Stevens J; Soice N; Benchaar SA; Hong RW; Goudar CT
    Biotechnol Prog; 2017 Nov; 33(6):1476-1482. PubMed ID: 29055113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of intraspecific and interspecific cloning in the conservation of wild mammals.
    Borges AA; Pereira AF
    Zygote; 2019 Jun; 27(3):111-117. PubMed ID: 31182179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cloning of mammals--biological aspects].
    Fulka J; Mrázek M
    Cas Lek Cesk; 2004; 143(5):295-8. PubMed ID: 15305762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction.
    Beaubier NT; Hart AP; Bartolo C; Willman CL; Viswanatha DS
    Diagn Mol Pathol; 2000 Sep; 9(3):121-31. PubMed ID: 10976718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning human stem cells.
    Choi S
    CMAJ; 2004 Mar; 170(7):1090. PubMed ID: 15051688
    [No Abstract]   [Full Text] [Related]  

  • 38. Cloning in reproductive medicine.
    Illmensee K
    J Assist Reprod Genet; 2001 Aug; 18(8):451-67. PubMed ID: 11599466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review: production, characterization, and testing of banked mammalian cell substrates used to produce biological products.
    Schiff LJ
    In Vitro Cell Dev Biol Anim; 2005; 41(3-4):65-70. PubMed ID: 16029074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of monoclonality from sequential dilution assays.
    Koziol JA
    Comput Methods Programs Biomed; 1989 Jul; 29(3):173-8. PubMed ID: 2673657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.